UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
__________________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 25, 2007
__________________________________
BIOVERIS CORPORATION
(Exact name of Registrant as specified in its charter)
|
|
Delaware |
000-50583 |
80-0076765 |
|
|
(State or Other Jurisdiction |
(Commission File Number) |
(I.R.S. Employer |
|
|
Of Incorporation) |
Identification Number) |
|
|
16020 Industrial Drive |
|
|
Gaithersburg, MD 20877 |
(Address of Principal Executive Offices and Zip Code)
_____________________________
(301) 869-9800
(Registrant’s Telephone Number, Including Area Code)
_____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On January 25, 2007, BioVeris Corporation (the “Company”) announced that it entered into a new Technology License Agreement with Baxter Healthcare Corporation. See the attached press release of the Company dated January 25, 2007 filed herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated January 25, 2007
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: January 25, 2007 |
BIOVERIS CORPORATION
By:/s/ George V. Migausky Name: George V. Migausky Title: Vice President of Finance and Chief Financial Officer
|
|
|
|
EXHIBIT INDEX
|
Exhibit 99.1 |
Press Release dated January 25, 2007 |